Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print May 9, 2008
DOI: 10.2337/db08-0157

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Sam, S.
Right arrow Articles by Mazzone, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sam, S.
Right arrow Articles by Mazzone, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Relationship of Abdominal Visceral and Subcutaneous Adipose Tissue to Lipoprotein Particle Number and Size in Type 2 Diabetes

Susan Sam1, Steven Haffner2, Michael H. Davidson3, Ralph B. D'Agostino4, Steven Feinstein5, George Kondos6, Alfonso Perez7, and Theodore Mazzone1

1Department of Medicine, Section of Endocrinology, Diabetes and Metabolism, Chicago, IL
2Department of Medicine, University of Texas Health Science Center, San Antonio, Texas
3Pritzker School of Medicine, The University of Chicago, Chicago, IL
4Department of Mathematics, Statistics and Consulting Unit, Boston University, Boston, MA
5Department of Medicine, Section of Cardiology, Rush University Medical Center, Chicago, IL
6Department of Medicine, Section of Cardiology, University of Illinois College of Medicine, Chicago, IL
7Takeda Global Research and Development, Ltd., Deerfield, IL

Objective: Insulin resistance and type 2 diabetes (DM2) are associated with an atherogenic lipoprotein profile. We examined the role of visceral and subcutaneous fat depots, independent of BMI, on the dyslipidemia associated with DM2.

Research Design and Methods: Three hundred eighty-two subjects with DM2 underwent abdominal computed tomography to evaluate subcutaneous (SAT) and visceral (VAT) adipose tissue distribution, and had anthropometric measurements to determine BMI, waist and hip circumference. Fasting blood was obtained for lipoprotein particle number and size using nuclear magnetic resonance spectroscopy. The relationship of lipoprotein particle number and size to BMI, SAT and VAT was examined using multivariable regression models adjusted for age, sex, diabetes therapy, duration of diabetes, smoking, statin use and hemoglobin A1c levels. The relation of VAT to lipoprotein particle number and size was further evaluated after the addition of BMI, BMI plus SAT, or BMI plus HOMAIR to the model.

Results: VAT was positively related to VLDL particle number (P<0.0001), LDL particle number (P<0.01), VLDL size (P<0.0001) and negatively related to LDL size (P<0.0001) and HDL size (P<0.0001). These relationships remained unchanged after addition of BMI and SAT to the model. After Addition of HOMAIR, VAT remained positively related to VLDL particle number (P<0.0001) and size (P<0.01) and negatively related to LDL and HDL particle size (P<0.0001 for both comparisons). Neither BMI nor SAT were independently related to lipoprotein parameters.

Conclusions: In patients with DM2, higher VAT independent of BMI, was associated with higher VLDL and LDL particle number, larger VLDL particles and smaller LDL and HDL particles. This lipoprotein pattern has been associated with increased risk for atherosclerosis and cardiovascular disease.


Correspondence: tmazzone{at}uic.edu


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.